We are live on ! Find out more
VCNX

Vaccinex, Inc. Common Stock
VCNX

Delisted

VCNX was delisted on the 17th of December, 2024.

Back to rankings

12 hedge funds and large institutions have $10.7M invested in Vaccinex, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

909% more capital invested

Capital invested by funds: $1.06M → $10.7M (+$9.64M)

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

20% more funds holding

Funds holding: 10 → 12 (+2)

Holders
12
Holders Change
+2
Holders Change %
+20%
% of All Funds
0.26%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
3
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MP
MSD Partners
New York
+$6.57M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$397K
3
OC
Oppenheimer & Co
New York
+$70.9K
4
UBS Group
UBS Group
Switzerland
+$12.4K
5
BlackRock
BlackRock
New York
+$3.38K

Top Sellers

Rank Fund Capital Flow
1
TI
Telemetry Investments
New York
-$67K
2
PAM
Panagora Asset Management
Massachusetts
-$13.5K
3
Millennium Management
Millennium Management
New York
-$7.88K

VCNX Hedge Fund Activity: Q3 2019 in Review

12 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Vaccinex, Inc. Common Stock (VCNX) for Q3 2019, worth a combined $10.7M — up 909% from $1.06M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new VCNX positions and 1 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.

The largest buyer was MSD Partners, opening a new position worth an estimated $6.57M. The largest seller was Telemetry Investments, exiting entirely with an estimated $67K sold.

  • 12 institutional investors held Vaccinex, Inc. Common Stock (VCNX) as of Q3 2019, up from 10 in Q2 2019.
  • Funds reported $10.7M of Vaccinex, Inc. Common Stock stock for Q3 2019, up 909% quarter-over-quarter.
  • 3 funds opened new Vaccinex, Inc. Common Stock positions in Q3 2019 and 1 closed out, a net change of +2 holders.
  • The largest Vaccinex, Inc. Common Stock buyer in Q3 2019 was MSD Partners, an estimated $6.57M added.
  • The largest Vaccinex, Inc. Common Stock seller in Q3 2019 was Telemetry Investments, an estimated $67K sold.

Based on aggregated 13F filings for Q3 2019.